Neuroscience
From the NIH:
Webpage: click here
- Alzheimer's Disease: Gammagard Fails
From the company press release: Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease DEERFIELD, Ill., May 7, 2013 - Baxter International Inc. (NYSE:BAX) today announced that its Phase III clinical study of...
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Neuropsychology Abstract Of The Day: Aging And Cognition
Subjective Cognitive Complaints of Older Adults at the Population Level: An Item Response Theory Analysis Alzheimers Disease and Associated Disorders. 2011 Dec 20; Snitz BE, Yu L, Crane PK, Chang CC, Hughes TF, Ganguli M Abstract Subjective cognitive...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...
- Neuropsychology Abstract Of The Day: Alzheimer Disease
Atchison TB, Massman PJ, & Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Archives of Clinical Neuropsychology. 2006 Dec 13; [Epub ahead of print]. Department...
Neuroscience
Alzheimer's Disease: Watch NIH Conference Live Online
From the NIH:
NIH State-of-the-Science Conference: Preventing Alzheimer's Disease and Cognitive Decline - Day 1
View event: You will be able to view the event at http://videocast.nih.gov when the event is live.
Air date: Monday, April 26, 2010, 8:30:00 AM
Time displayed is Eastern Time, Washington DC Local
[snip]
Description: For many older adults, cognitive health and performance remain stable, with only a gradual and slight decline in short-term memory and reaction times. Others, however, progress into a more serious state of cognitive impairment or into various forms of dementia, including Alzheimer’s disease. In addition to investigating the causes and potential treatments for Alzheimer’s and other dementias, researchers are focused on finding ways to prevent cognitive decline. Many preventive measures for cognitive decline and for preventing Alzheimer’s have been suggested, but their value in delaying the onset and/or reducing the severity of decline or disease is unclear. Be part of pivotal discussions that will help answer critical questions related preventing Alzheimer's disease and cognitive decline.
http://consensus.nih.gov/2010/alz.htm
Author: Sponsored by the National Institute on Aging Office of Medical Applications of Research
Runtime: 600 minutes
Webpage: click here
- Alzheimer's Disease: Gammagard Fails
From the company press release: Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease DEERFIELD, Ill., May 7, 2013 - Baxter International Inc. (NYSE:BAX) today announced that its Phase III clinical study of...
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Neuropsychology Abstract Of The Day: Aging And Cognition
Subjective Cognitive Complaints of Older Adults at the Population Level: An Item Response Theory Analysis Alzheimers Disease and Associated Disorders. 2011 Dec 20; Snitz BE, Yu L, Crane PK, Chang CC, Hughes TF, Ganguli M Abstract Subjective cognitive...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...
- Neuropsychology Abstract Of The Day: Alzheimer Disease
Atchison TB, Massman PJ, & Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Archives of Clinical Neuropsychology. 2006 Dec 13; [Epub ahead of print]. Department...